Sentences with phrase «federal funding programs»

Federal funding programs advancing the strategy's innovation goals have already been launched.

Looking for additional resources to navigate the complex issues that surround federal funding programs?

You may have heard SSAEG described in more political terms as a new $ 1.6 billion ESSA program that consolidates about 50 different federal funding programs into one state block grant.

Yet while federal funding programs for magnet schools require them to outline how they will prevent...

For detailed information on Federal funding programs, see Funding Opportunities.

This section includes information on Federal funding programs, as well as current grants and solicitations.

Together, the committee hopes their suggested modifications of current training activities and federal funding programs will allow the U.S. to «more comprehensively address the health problems of today and tomorrow.»

Federal funded programs, FTE counts and enrollment will also be effected.

Conduct outbound calls to offer current Medicare members state and federal funded programs that may improve their way of life

Not exact matches

At the end of October, the Highway Trust Fund becomes insolvent, lacking the funding it needs to continue projects that repair and build the nation's federal, state, and local highways, bridges, tunnels and mass transit programs.

The trust fund is paid for with receipts from the federal fuel tax, and with gas prices at low levels, an increase in the tax might be part of a more extended program.

These programs provide free one - on - one mentoring and low - cost training opportunities for their clients in locations around the country, using a combination of federal funds, state and local government contributions, and private sector resources.

As most unregulated lenders insure their mortgages and rely on CMHC securitization programs or the major banks for their funding, most of their mortgages must comply with federal mortgage rules.»

Edith Cowan University's Vario Health Institute is seeking federal funding to support its preventative health research programs.

CPB president Patricia Harrison said in a statement that there was «no viable substitute for federal funding» that could help the CPB provide free public media programming, which was slashed from the budget that Trump released Thursday.

The approximately $ 6.8 billion bill will fund major federal initiatives like Vice President Joe Biden's Cancer Moonshot program and the Obama administration's Precision Medicine Initiative.

She'd also use federal dollars to fund a national paid family and medical leave program, which would give every worker some portion of their paycheck for up to 12 weeks.

Meanwhile, the report points out, federal funding for housing assistance programs has actually declined by 3 percent in the last seven years.

No matter where one stands on the debate over safety - net programs like welfare and food stamps, or massive federal undertakings like Obamacare, everyone agrees that those need taxation to fund them.

WASHINGTON, March 26 - Federal Communications Commission Chairman Ajit Pai on Monday said he was proposing new rules to bar the use of funds from a government program to purchase equipment or services from companies that pose a security threat to U.S. communications networks.

Federal programs are increasing funding for those organizations, Peterson said.

Several existing federal programs like the Community Reinvestment Act and the Small Business Investment Companies program are supporting the growth of impact investing funds.

If the new administration really wants to restore U.S. manufacturing, fix the trade deficit, and boost innovation, it should leverage the best ideas that come from federal research programs and invest in funding the next big thing.

Parliamentary budget officer Jean - Denis Frechette's office found 10,052 projects with a combined cost to federal coffers of $ 7.2 billion have been approved for funding across 32 departments, agencies and Crown corporations since 2016, when the Liberals unveiled the first phase of their infrastructure program,.

The federal government has called on businesses, local and state governments, and residents of the tourist areas to help fund the program, and the rule of law and political institutions still need to be strengthened, said de la Madrid.

Boston and Washington, D.C., for example, use a mix of federal, state, and city money to fund their programs, while New York City's bike - sharing initiative is financed entirely by private means.

Edith Cowan University is one of two universities nationally that will share in $ 1.9 million in federal funding to boost its cyber security program.

«They undoubtedly are dependent on some special legislation or some under - the - table benefits with Medicaid and with education programs going forward that the federal deficit will have to fund,» he says.

James Richardson, alumni professor of economics at Louisiana State University, in May noted that the state had an obligation to fund care for uninsured patients whether or not it expanded Medicaid, and estimated that Louisiana stood to gain between $ 810 million to $ 864 million in federal support by expanding the program.

A NEW Federal Government - funded program will help small to medium enterprises take advantage of international trade on the Internet.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

The Federal Government - funded Year2K Industry Program plans to introduce an Information Disclosure Act or «Good Samaritan» legislation that will address Y2K liability risks under the Trade Practices Act.

Ontario has the lowest per - capita program spending among provinces and the lowest total government revenue per person among all Canadian provinces, including funding from federal transfers.

Two more federal judges have ordered the Trump administration to restore funding for teen pregnancy prevention programs that were abruptly eliminated.

In its early years, a number of her students in the program were teenagers who had come to the country, unauthorized, at a young age and finished high school, but then could not obtain citizenship or receive any state or federal funds for college.

During this period, the Federal Reserve tried to support employment by cutting its federal funds rate target nearly to zero; by creating a number of special liquidity facilities to support the extension of credit; and by engaging in a large scale asset purchase program, buying Treasuries, agency debt and agency mortgage - backed secuFederal Reserve tried to support employment by cutting its federal funds rate target nearly to zero; by creating a number of special liquidity facilities to support the extension of credit; and by engaging in a large scale asset purchase program, buying Treasuries, agency debt and agency mortgage - backed secufederal funds rate target nearly to zero; by creating a number of special liquidity facilities to support the extension of credit; and by engaging in a large scale asset purchase program, buying Treasuries, agency debt and agency mortgage - backed securities.

Harper did not announce any more money for the Conservative's federal renewable energy program, which runs out of funding this year.

Reduces surging crime, drugs and violence by creating a Task Force On Violent Crime and increasing funding for programs that train and assist local police; increases resources for federal law enforcement agencies and federal prosecutors to dismantle criminal gangs and put violent offenders behind bars.

(The Federal Housing Administration has estimated that losses on mortgages that relied on seller - funded down payment assistance programs funded by homebuilders may end up costing FHA more than $ 15 billion).

First, by the end of 2014, following the large - scale asset purchase programs, the Federal Reserve balance sheet was funded by about $ 3.1 trillion in liabilities other than Federal Reserve notes, which were mostly in the form of reserves in excess of the amount banks were required to hold; in contrast, there were only $ 64 billion of non-Federal Reserve note liabilities in June 2007, of which only about $ 2 billion were excess reserves.

Their analysis concludes that the programs contributed an estimated $ 20 billion to the Federal Reserve's interest and fee income during that period, or $ 13 billion after taking into account the estimated $ 7 billion cost of funds.

Jeff Dion, National Compassion Fund director, said that funding would come from programs run by the federal and state governments.

With the ending of the stimulus funding and the repayment of the principal on assets maturing under the Insured Mortgage Purchase Program, the federal government's new borrowing requirements are falling dramatically.

There is a limited amount of federal funding for this loan program, and the loans are offered at a low, fixed 5 percent interest rate.

Both programs were designed to provide faith - based charity organizations with a clear avenue to get federal funding for their work.

Reining In Rates O'Neil, one of the managers of the $ 26 billion Fidelity Total Bond Fund, said rising bond yields could be reined in by at least three forces: Federal Reserve Chair Janet Yellen's commitment to a very gradual program of rate hikes, the traditional aversion to budget deficits by the Republican - controlled Congress, and buying by overseas investors who may use the recent jump in rates to snap up more Treasuries.

The federal government offers a kind of insurance of its own through a fund called the Disaster Financial Assistance Arrangements program, which helps provinces and territories recover from natural disasters.

The initial $ 220 million investment in the fiber optic system was funded, in part, by a $ 111.6 million federal grant provided as part of the federal stimulus program in 2010 designed to spur jobs and the development of a smarter electric grid.

Funded through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) and with support from the Canadian Innovation Centre (CIC) and a consortium of other non-profit Regional Innovation Centres, including MaRS, the program is geared to train as many as 450 entrepreneurs over 15 months, and provide as much as $ 4 million in seed financing to qualified applicants.

The following options may be available to students in need of loans to fund their education under the federal student loan program: